Company intelligence
SSI Strategy
Building Better Biotechs
About SSI Strategy
At SSI Strategy, we're strategic partners deeply invested in our clients' success. We offer a unique, adaptive approach to supporting biotech companies, integrating business acumen with deep expertise in Clinical Development & Operations, Regulatory affairs, Pharmacovigilance, Medical Affairs, Quality and more. Our agile skills and resources model allows us to adapt to your specific needs, working as an embedded team within your organization. We complement your existing teams, scaling specialized skill sets up and down as needed, while equipping them with the tools and resources to operate at peak performance. By fostering the organization you want to build, we position your full-time employees to be more successful and effective in their strengths. As your needs evolve, so does our support. We offer deep expertise, strategic insight, and a comprehensive range of services to help you navigate the challenges of bringing a therapeutic from concept to commercialization. Our mission is clear: Build better biotechs through seamless collaboration, informed decision-making, and accelerated progress.
Verified activity
Signals from SSI Strategy
4 published signals
Presence & Recognition
SSI Strategy is hosting a strong line-up of events in Boston, San Diego, Madrid, and Milan for the rest of 2026.
Reported by SSI Strategy
Research & Knowledge
SSI Strategy read six Western pharma partnering forms including Merck, Novartis, Pfizer, Sanofi, BMS, and J&J field by field.
Reported by John Xu, MD, MBA, MS
Research & Knowledge
SSI Strategy published a new article in Frontiers in Medicine examining New Approach Methodologies (NAMs) from scientific, regulatory, and strategic perspectives.
Reported by SSI Strategy
Presence & Recognition
SSI Strategy attended the ESC Congress event in 2026.
Reported by SSI Strategy